Protein Interaction Assay

About Actome

Actome is a proteomics company commercializing its innovative PICO technology, which merges immunoassay principles with digital PCR readout to achieve femtomolar sensitivity and absolute quantification of protein targets without reference standards. Its platform aims to displace traditional, cumbersome methods like Western blot, ELISA, and co-immunoprecipitation, particularly in areas such as extracellular vesicle characterization, biomarker detection, and signaling pathway analysis. The company appears to be in an early commercial stage, offering kits and services while engaging in publicly funded research projects to further develop its platform and software analytics.

Therapeutic Areas